The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.
The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope
Global Anaesthesia Drugs Market forecasts from 2019-2029
Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
  • Local Anaesthesia Drugs
  • General Anaesthesia Drugs

This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
  • Benzocaine
  • Bupivacaine
  • Chloroprocaine
  • Lidocaine
  • Prilocaine
  • Ropivacaine
  • Others
This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
  • Desflurane
  • Dexmedetomidine
  • Midazolam
  • Propofol
  • Remifentanil
  • Sevoflurane
  • Others
This report shows forecasts to 2029 for the market segmented by route of administration:
  • Inhalation Anaesthesia Drugs
  • Intravenous Anaesthesia Drugs
  • Topical Anaesthesia Drugs
Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
  • North America: US and Canada
  • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
  • RoW: Brazil, Mexico, Russia, South Africa
Each regional and national market is further segmented by type, drug and route of administration.
This report discusses these selected leading companies:
  • Baxter International, Inc.
  • AbbVie
  • Pfizer
  • Hameln Pharmaceuticals
  • AstraZeneca
  • Fresenius Kabi
  • Maruishi Pharmaceuticals
  • Pacira Pharmaceuticals, Inc
Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.
  • This report discusses promising drug candidates which are under development for the anaesthesia drugs market.
  • Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.